This study tests an experimental pill called ATRN-119 in people with advanced solid tumors that have certain DNA repair mutations. The goal is to see if the drug is safe and can shrink tumors. About 132 participants will take the drug by mouth, and researchers will monitor side e…
Phase: PHASE1, PHASE2 • Sponsor: Aprea Therapeutics • Aim: Disease control
Last updated May 12, 2026 13:42 UTC